Improving immune reconstitution with growth hormone [somatropin] in HIV-infected subjects with incomplete CD4+ lymphocyte restoration on highly active antiretroviral therapy (HAART)

Trial Profile

Improving immune reconstitution with growth hormone [somatropin] in HIV-infected subjects with incomplete CD4+ lymphocyte restoration on highly active antiretroviral therapy (HAART)

Completed
Phase of Trial: Phase II

Latest Information Update: 17 May 2012

At a glance

  • Drugs Antiretrovirals; Somatropin
  • Indications HIV infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 03 May 2012 Actual end date Mar 2005 added as reported by ClinicalTrials.gov.
    • 05 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Apr 2010 Results have been published in AIDS Research and Human Retroviruses.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top